Adenovirus-mediated gene transfer to dendritic cells is highly efficient and often used, but the relationship among cell maturation, viral infection and expression of a transferred gene remains unclear. To study this relationship, we introduced a recombinant replication-defective adenovirus encoding the gene for green fluorescent protein to normal human immature myeloid dendritic cells. We induced maturation by the addition of TNF-␣, IL-1␤, IL-6 and prostaglandin E 2 to the medium and assessed cell maturity by the levels of the secreted p40 subunit of IL-12 and of membrane-bound CD83. We quantified the efficiency of gene expression by GFP fluorescence and analyzed the data by a mixed-model analysis of variance; the model explained more than 97% of the effects. CD83 expression and p40 secretion depended solely on incubation time and maturation medium. The cells
Dendritic cells are unique in the ability to recruit naive immune effector cells and to stimulate memory effector cells. 1 This feature prompted numerous studies of antigen-loaded dendritic cells in initiation and maintenance of immunity against cancer and infectious diseases. 2 Antigen loading has been accomplished by many methods, including infection with recombinant replication-defective adenoviruses. 3, 4 In vivo, adenovirusmediated genes are expressed in transient 'bursts' that reach maximum in 3 days and last up to 6 days. 5 Such kinetics of protein expression together with the occurrence of circulating adenovirus-specific antibodies before 6 and after adenovirus injection [6] [7] [8] prompted the notion that adenoviruses are of limited therapeutic use, particularly in gene transfer to somatic cells. However, adenoviruses could be the vectors of choice for ex vivo gene transfer to dendritic cells. Namely, the burst in adenovirus-borne protein expression coincides with dendritic cell maturation and function. 4 Contrary to injected adenoviruses, adenoviruses used for ex vivo gene transfer cultured in the absence of maturation medium remained immature and maintained the ability to respond to the later addition of the maturation irrespective of adenovirus infection and transferred gene expression. This expression was independent of cell maturation. In comparison with mature cells, the transferred gene was expressed in immature dendritic cells with a lag compatible with the less effective initial step (infection and/or gene transfer) in the absence of the maturation medium rather than less effective later GFP synthesis. Expression of CD83 and p40 were unaffected by adenovirus infection and transferred gene expression. Thus, immature dendritic cells infected with recombinant adenoviruses can be matured when desired after transferred gene expression. Gene Therapy (2001) 8, 419-423. into dendritic cells do not induce strong humoral responses. 9 In comparison with other methods of antigen delivery to dendritic cells, adenoviruses were most efficient. 3 Adenovirus-transduced dendritic cells induced tumorspecific cytotoxic T cells 8,10,11 and protected from tumor challenge. [12] [13] [14] These advantages of adenoviruses necessitate a fuller understanding of the interactions of infection, expression of transferred and endogenous genes and dendritic cell maturation (terminal differentiation). Infection by recombinant adenovirus and the expression of the adenovirus-borne green fluorescent protein (GFP) interfere neither with dendritic cell maturation 4 nor with the induction of allogeneic mixed lymphocyte reaction by infected dendritic cells. 15 However, the nature of the relationship among maturation, infection and expression of transferred genes remains unclear. For example, it is not known whether immature dendritic cells are as effective as mature dendritic cells in expressing the transferred gene or if they maintain the ability to respond to the later addition of the maturation medium once infected and expressing the transferred gene. Such information is relevant for studies of the role of dendritic cell maturation in priming and boosting immunity in vivo. In other words, it is important to determine whether one can attain the same level of expression of an adenovirusborne gene in dendritic cells at different stages of maturation.
We derived immature dendritic cells by incubating CD14-positive cells isolated from normal human blood and incubated with IL-4 and GM-CSF for 7 days. 16, 17 On day 7, we introduced to cells the recombinant replicationdefective adenovirus (lacking functional E1 and E3 genes) encoding the gene for green fluorescent protein (AdGFP) or the control virus devoid of that gene (AdCon) and incubated for 6 more days as described in the legend to Figure 1 . Maturation was induced on day 7 (open symbols in Figures 1-3 ) or day 10 (solid symbols) by the medium containing tumor necrosis factor ␣ (TNF-␣), interleukin 1␤ (IL-1␤), IL-6 and prostaglandin E 2 (PGE 2 ), 16, 17 the 'maturation medium'. Expression of membrane molecules, morphology and viability of mature dendritic cells incubated with AdCon and AdGFP did not differ from mature dendritic cells incubated in the absence of viruses, in agreement with our previous data. 4 Consequently, we used the levels of the membranebound CD83 as a measure of cell maturity 18, 19 in uninfected cells and cells infected with viruses. Figure 1 shows the percentage of CD83-positive dendritic cells as a function of time in uninfected cells and in cells infected with AdCon or AdGFP.
We analyzed the data by considering three independent variables (incubation time, day of maturation medium introduction and type of virus -AdCon, AdGFP or none) and two responses (the percent of cells expressing CD83 and total GFP expression reported as mean fluorescence intensity, MFI). By a mixed-model analysis of variance we assessed the effects of independent variables on cell maturation and GFP expression. The three experimental variables accounted for 90.1% of change in the levels of CD83-positive cells. After accounting for individual differences among different independent replicates, the model explained 97.4% of change. The amount of CD83-positive cells differed for the combinations of incubation lengths and maturation medium introduction times ( Table 1 ). The interaction between incubation time and maturation medium introduction time explained the bulk of the variability in CD83 expression (P = 0.0001; Figure 1 ). In cells incubated with the maturation medium from day 7, the percentage of CD83-positive cells increased strongly on day 8 and reached a maximum on day 10. The levels of CD83-positive cells incubated in the absence of the maturation medium for the first 3 days of measurements remained rather stable. However, introduction of the maturation medium on day 10 strongly induced CD83-positive cells on day 11; this rate of induction was higher than in cells incubated with the maturation medium from day 7. This finding indicates that the cells maintained the ability to respond to the later introduction of the maturation medium. This effect was not influenced by infection by AdCon or AdGFP (P = 0.74).
To determine if infection affects cytokine secretion by dendritic cells, we monitored the levels of the p40 unit of IL-12 secreted into the cell culture medium 1 in proportion to mature dendritic cells in the population. 20 We measured p40 in the supernatants of the cells described in Figure 1 and found that the levels of this molecule closely followed the levels of CD83 with a 1-day lag ( Figure 2 ). The lag might reflect the differences in regulation of gene expression and/or in the post-translational processing inherent in secretion. None the less, the levels of p40 confirm independently that neither the infection 17 by the adenovirus nor the expression of the transferred gene interferes with dendritic cell maturation and other cellular functions.
We measured the intracellular levels of adenovirusborne GFP to determine the effects of dendritic cell maturation on the expression of the transferred gene ( Figure  3 ). In the cells incubated with maturation medium from Statistical analysis. We assessed the impact of incubation time, day of maturation medium introduction and infection on the expression of CD83 and GFP (expressed as lnGFP) by the use of a mixed-model analysis of variance that included fixed and random terms (effects). The models complied with the assumptions required for the use of the classical mixed-model analysis of variance. P values less than 0.05 were considered statistically significant, ie expression levels were affected by the experimental variables. Figure 1 . day 7, GFP levels increased exponentially throughout the experiment (note the logarithmic ordinate in Figure 3 ). After day 10, the rate of increase was somewhat slower, either because of the lower rate of synthesis or of the higher rate of degradation or both. In the cells infected with the virus in the absence of maturation medium, GFP expression lagged by approximately 1 day behind the cells infected in the presence of these molecules. The similar slopes of the two lines in Figure 3 demonstrate that the rate of GFP accumulation was similar in the two groups of cells (and verify independently that the cells remained viable throughout experiments). Thus, the lag in the onset of GFP accumulation is compatible with the less effective initial step (infection and/or gene transfer) in the absence of the maturation medium rather than less Gene Therapy
Figure 2 Infection by recombinant adenovirus and expression of a transferred gene do not impair secretion of the p40 subunit of IL-12 by dendritic cells. Meaning of symbols as in

Figure 3 Increase of the levels of the green fluorescent protein (GFP) in dendritic cells incubated with maturation medium from day 7 (open symbols) and from day 10 (solid symbols), respectively. Squares, cells infected with AdGFP; circles, cells infected with AdCon; triangles, mockinfected cells. The levels of GFP are expressed as the natural logarithm of the total geometric mean fluorescence intensity (logMFI) measured with the flow cytometer set for fluorescein detection. The logarithmic transformation allowed us to utilize analysis of variance techniques to make statistical comparisons.
effective later GFP synthesis. Significantly, introduction of the maturation medium on day 10 had no effect on the rate of GFP accumulation. The three independent variables (incubation time, maturation medium introduction time and presence of the virus) accounted for 96.6% of the change in the levels of GFP-positive cells. After accounting for individual differences in cell cultures, the model explained 98.9% of change. Expression of GFP depended on combinations of all three independent variables (P = 0.0036). Cells infected by AdGFP and incubated under any condition expressed GFP. However, cells incubated in the maturation medium from day 7 began accumulating GFP earlier than those incubated in the maturation medium from day 10 ( Figure 3) . We determined the extent of interdependence of dendritic cell maturation and expression of the transferred gene. As expression of both CD83 and GFP was influenced by incubation time, maturation medium introduction time and virus type (Figures 1 and 3) , we had to account for the effects of experimental conditions by subtracting the mean values in Figures 1 and 3 , respectively, from individual measurements. This manipulation yielded residuals independent of experimental conditions (Figure 4) . The Pearson correlation coefficient between the residuals for CD83 and GFP was −0.094 and the P value was 0.3390, indicating that the levels of CD83 and GFP were not significantly correlated. In other words, AdGFP infection and GFP expression did not affect dendritic cell maturation as measured by the CD83 levels; conversely, GFP expression did not depend on the maturation stage of dendritic cells.
To characterize the effects of adenovirus infection and transgene expression on dendritic cells more fully, we infected the cells on day 7 with 40% less adenovirus and Gene Therapy liposomes than the cells in Figures 1-3 . However, 47.4 ± 19.6% of infected immature cells expressed GFP compared with above 90% when infected as in Figures 1-3 . 4 The cells were incubated with or without maturation cocktail for 3 days when we measured the levels of CD25 (allophycocyanin conjugate, PharMingen, San Diego, CA, USA) CD80 (Cy-Chrome labeled, PharMingen), CD83 and GFP by four-color flow cytometry. Data were analyzed by logical gating combining forward scatter, side scatter, green and non-green fluorescence modes. Gated cells were independently evaluated for the percentage of cells positive for CD25, CD80 and CD83.
In uninfected immature dendritic cells, the levels of CD25, CD80 and CD83 were low (0.1 ± 0.1%, 5.0 ± 7.9% and 1.5 ± 0.8%, respectively). Infection did not change the levels of CD25 relative to uninfected cells (P = 0.68). GFPnegative cells contained 21.7 ± 2.6% of CD80-positive cells, not significantly different from uninfected cells (P = 0.056). GFP-positive cells contained 43.3 ± 4.3% CD80-positive cells, an increase from GFP-negative cells (P = 0.0038). Similarly, the levels of CD83-positive cells were not statistically different in uninfected cells (1.5 ± 0.8%) and GFP-negative infected cells (4.2 ± 1.4%; P = 0.053), but GFP-positive cells contained more CD83-positive cells (16.2 ± 5.0%) than GFP-negative cells (P = 0.045). When fully matured, infected dendritic cells were 71.5 ± 2.5% CD25-positive, 92.2 ± 1.8% CD80-positive and 89.7 ± 3.5% CD83-positive (all P Ͻ 0.0001 relative to uninfected and infected immature cells). Even with these changes, adenovirus infection, transgene expression and dendritic cell maturation were largely uncoupled.
This study of time-dependent interactions of dendritic cell maturation and expression of an adenovirusmediated gene has been prompted by the need to define dendritic cells at different stages of maturation expressing controlled levels of a transferred gene. We analyzed the data by multivariate analysis and found that more than 97% of the effects were explained by the duration of incubation, by the presence of the maturation medium and the presence of the recombinant adenovirus. In other words, the system was fully controlled by the known experimental variables.
This study demonstrates that dendritic cell maturation can be delayed without sacrificing efficiency of transferred gene expression. Also, both immature and mature dendritic cells sustain accumulation of the transferred gene product for 6 days. This finding is at variance with Ref. 15 where cell survival and expression of the transferred gene were sustained only in the presence of TRANCE, a dendritic cell survival factor. The reason for the difference in viability of infected cells in this study and in Ref. 15 is unclear, but it might reside in our use of the maturation medium contrasted with the use of monocyte-conditioned medium or lipopolysaccharide in the other study.
In this quantitative analysis of time dependence in the relationship of dendritic cell maturation and expression of the transferred gene, we demonstrate that the gene transferred by a recombinant replication-defective adenovirus was expressed independently of maturation. In comparison with mature cells, the transferred gene was expressed in immature dendritic cells with a time lag attributed to the changes in the cell induced by the maturation medium. Our data agree with those in Refs 21 and 22 in finding limited up-regulation of costimulatory molecules in infected cells. However, infected immature dendritic cells maintained the ability to respond to the later addition of the maturation medium. These findings allow considerable latitude in engineering dendritic cells at different stages of maturation that express and present controlled levels of transferred gene products. Such cells are of interest for their roles in stimulating immunity and inducing immune tolerance, respectively.
